Bone Quality Index – Definition & Significance

What Is the Bone Quality Index?

The Bone Quality Index (BQI) is a diagnostic parameter that provides a comprehensive assessment of bone tissue quality. Unlike simple bone density measurements, which only quantify the mineral mass per unit volume, the Bone Quality Index also accounts for bone microarchitecture, material composition, and biomechanical load-bearing capacity. It is therefore an important tool in the diagnosis and ongoing monitoring of conditions such as osteoporosis.

Clinical Significance

Bone tissue is composed not only of mineral components such as calcium and phosphate, but also of an organic framework known as the collagen network. The quality of bone depends on both components. A bone may have normal density and yet be structurally weakened, which increases the risk of fracture. This is precisely where the Bone Quality Index adds value: it enables a more differentiated assessment of bone health than bone density measurements alone.

The index is primarily used for:

• Diagnosis and monitoring of osteoporosis
• Assessment of fracture risk
• Evaluating the effectiveness of bone-active medications
• Assessment of bone changes in metabolic diseases (e.g., diabetes mellitus, renal disease)
• Monitoring during long-term corticosteroid therapy

Components of the Bone Quality Index

The Bone Quality Index is composed of several sub-aspects that together provide a complete picture of bone health:

1. Bone Mineral Density (BMD)

Bone Mineral Density (BMD) is the most well-known component and is commonly measured using DXA (Dual-Energy X-ray Absorptiometry). It provides information about the mineral content of bone.

2. Microarchitecture

The three-dimensional structure of bone, particularly of the trabecular (spongy) bone tissue, significantly influences its mechanical stability. Advanced imaging techniques such as quantitative computed tomography (QCT) or high-resolution peripheral QCT (HR-pQCT) allow detailed evaluation of this structure.

3. Bone Turnover

Blood and urine markers such as osteocalcin, alkaline phosphatase, or collagen crosslinks allow assessment of bone remodeling activity. Elevated bone resorption markers may indicate reduced bone quality.

4. Material Quality

The chemical composition of bone mineral and the quality of the collagen matrix determine the elastic and mechanical properties of bone. These can be analyzed using specialized spectroscopic techniques such as Raman spectroscopy.

Measurement Methods

Depending on the clinical context, several methods are available to determine the Bone Quality Index:

• DXA (Dual-Energy X-ray Absorptiometry): Standard method for measuring bone density; fast, low-radiation, and widely available.
• Quantitative Computed Tomography (QCT): Provides three-dimensional information about bone density and structure.
• HR-pQCT (High-Resolution Peripheral QCT): Enables detailed microarchitectural analysis at peripheral skeletal sites (e.g., radius, tibia).
• Quantitative Ultrasound (QUS): A non-contact, radiation-free method that indirectly assesses bone elasticity and density.
• Bone Biomarkers in Blood and Urine: Laboratory tests to evaluate bone remodeling activity.

Factors Influencing Bone Quality

Bone quality is influenced by numerous factors:

• Age: Bone quality declines with increasing age; postmenopausal women are particularly affected.
• Nutrition: Adequate intake of calcium, vitamin D, and protein is essential for healthy bones.
• Physical Activity: Regular weight-bearing exercise stimulates bone formation.
• Hormonal Status: Estrogen and testosterone protect against bone loss.
• Medical Conditions: Diabetes mellitus, renal insufficiency, thyroid disorders, and inflammatory diseases can negatively affect bone quality.
• Medications: Long-term use of corticosteroids, proton pump inhibitors, or anticonvulsants can reduce bone quality.
• Smoking and Alcohol: Both factors are associated with reduced bone quality.

Treatment and Improvement of Bone Quality

When reduced bone quality is identified, several therapeutic approaches are available:

• Calcium and Vitamin D: Fundamental supplementation to support bone metabolism.
• Bisphosphonates: Medications that inhibit bone resorption and are used in the treatment of osteoporosis.
• Anabolic Therapies: For example, teriparatide, a parathyroid hormone analogue that stimulates bone formation.
• Exercise Therapy: Strength and endurance training to improve bone stability.
• Dietary Adjustment: A balanced, nutrient-rich diet providing adequate bone-relevant micronutrients.

References

1. Seeman, E. & Delmas, P.D. (2006): Bone quality - the material and structural basis of bone strength and fragility. New England Journal of Medicine, 354(21), 2250-2261.
2. Compston, J. et al. (2019): Osteoporosis. Nature Reviews Disease Primers, 5(1), 1-21. DOI: 10.1038/s41572-018-0060-3.
3. World Health Organization (WHO): Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, Geneva, 1994.